These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 36100635

  • 1. Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere.
    Luo Y, Fan Q, Yu Y, Zhang L, Dong L, Luo H.
    Sci Rep; 2022 Sep 13; 12(1):15363. PubMed ID: 36100635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
    Mizushima Y, Shiokawa Y, Homma M, Kashiwazaki S, Ichikawa Y, Hashimoto H, Sakuma A.
    J Rheumatol; 1987 Feb 13; 14(1):97-101. PubMed ID: 3553591
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipo-PGE1 suppresses collagen production in human dermal fibroblasts via the ERK/Ets-1 signaling pathway.
    Yang Y, Kim HJ, Woo KJ, Cho D, Bang SI.
    PLoS One; 2017 Feb 13; 12(6):e0179614. PubMed ID: 28644845
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lipo-PGE1, prostaglandin E1 incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion.
    Egashira T, Kim YI, Takayama F, Kudo Y, Yamanaka Y.
    Free Radic Biol Med; 1996 Feb 13; 21(3):353-6. PubMed ID: 8855446
    [Abstract] [Full Text] [Related]

  • 11. Interaction between non-ionic contrast medium and prostaglandin E1 incorporated in lipid microspheres: in-vitro comparative study of direct and non-direct mixing.
    Hayashi H, Uchiyama N, Kawamata H, Takagi R, Abe Y, Kumazaki T.
    Radiat Med; 2000 Feb 13; 18(4):219-25. PubMed ID: 11246996
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study.
    Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.
    Heart Vessels; 2013 Sep 13; 28(5):589-95. PubMed ID: 23000961
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy.
    Hong L, Zhang J, Shen J.
    J Diabetes Complications; 2015 Sep 13; 29(8):1283-6. PubMed ID: 26355026
    [Abstract] [Full Text] [Related]

  • 17. Uptake by vascular smooth muscle cells plays an important role in targeting of lipid microspheres incorporating prostaglandin E1 into a thickened intima.
    Chino Y, Minagawa T, Kohno Y, Toda Y, Murakami S, Higuchi S.
    Life Sci; 2001 Jan 12; 68(8):933-42. PubMed ID: 11213363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.